Drug-eluting medical implants
Disclosed are self-expanding medical implants for placement within a lumen of a patient. The implants comprise a woven or non-woven structure having a substantially tubular configuration, and are designed to be low-profile such that they are deliverable with a small diameter catheter. The implants have a high recoverability and desired mechanical properties.
1. A medical implant comprising: a tubular structure comprising polymeric strands and open spaces between adjacent said polymeric strands, said polymeric strands comprising a first polymeric material; a first conformal coating at least partially coating said polymeric strands; and a second conformal coating at least partially coating said first conformal coating and comprising a second polymeric material and an amount of paclitaxel as a single therapeutic agent in said medical implant; wherein each of said polymeric strands has a cross-sectional diameter within the range of about 0.003 to about 0.007 inches, wherein said tubular structure is characterized by a surface area, and the amount of paclitaxel is within the range of about 0.002 to about 0.175 micrograms per square millimeter of said surface area.
2. The medical implant of claim 1 , wherein said tubular structure comprises at least 32 strands.
3. The medical implant of claim 2 , wherein the amount of paclitaxel is within the range of about 0.002 to about 0.09 micrograms per square millimeter of said surface area.
4. The medical implant of claim 1 , wherein said tubular structure comprises at least 24 strands.
5. The medical implant of claim 4 , wherein the amount of paclitaxel is within the range of about 0.003 to about 0.12 micrograms per square millimeter of said surface area.
6. The medical implant of claim 1 , wherein said tubular structure comprises at least 16 strands.
7. The medical implant of claim 6 , wherein the amount of paclitaxel is within the range of about 0.004 to about 0.175 micrograms per square millimeter of said surface area.
8. The medical implant of claim 1 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.1 to about 2.0 micrograms per millimeter of length of said tubular structure.
9. The medical implant of claim 1 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.2 to about 2.0 micrograms per millimeter of length of said tubular structure.
10. The medical implant of claim 1 , wherein said second conformal coating has a thickness up to 8 microns.
11. The medical implant of claim 1 , wherein the amount of paclitaxel is within the range of about 0.002 to about 0.02 micrograms per square millimeter of said surface area.
12. The medical implant of claim 11 , wherein said tubular structure comprises between about 16 and about 32 strands.
13. The medical implant of claim 12 , wherein the first polymeric material is poly(lactic acid co-glycolic acid), wherein said first conformal coating comprises crosslinked poly(lactic acid-co-caprolactone) and wherein said second polymeric material is poly(lactic acid-co-caprolactone) that is not crosslinked.
14. A medical implant comprising: a tubular structure comprising polymeric strands and open spaces between adjacent said polymeric strands, said polymeric strands comprising a first polymeric material; a first conformal coating at least partially coating said polymeric strands; and a second conformal coating at least partially coating said first conformal coating and comprising a second polymeric material and an amount of paclitaxel as a single therapeutic agent in said medical implant; wherein said tubular structure is characterized by a surface area, wherein the amount of paclitaxel is within the range of about 0.002 to about 0.175 micrograms per square millimeter of said surface area, and wherein said tubular structure has a surface area within the range of about 11.4 to about 53.8 square millimeters per millimeter of length of said tubular structure.
15. The medical implant of claim 14 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.1 to about 2.0 micrograms per millimeter of length of said tubular structure.
16. The medical implant of claim 14 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.2 to about 2.0 micrograms per millimeter of length of said tubular structure.
17. The medical implant of claim 14 , wherein the amount of paclitaxel is within the range of about 0.002 to about 0.02 micrograms per square millimeter of said surface area.
18. The medical implant of claim 17 , wherein said tubular structure comprises between about 16 and about 32 strands.
19. The medical implant of claim 18 , wherein the first polymeric material is poly(lactic acid co-glycolic acid), wherein said first conformal coating comprises crosslinked poly(lactic acid-co-caprolactone) and wherein said second polymeric material is poly(lactic acid-co-caprolactone) that is not crosslinked.
20. A medical implant comprising: a tubular structure comprising between 16 and 32 polymeric strands woven into together to form said tubular structure, each of said polymeric strands having a cross-sectional diameter within the range of about 0.003 to about 0.007 inches; a conformal coating at least partially coating said polymeric strands and comprising an amount of paclitaxel as a single therapeutic agent in said medical implant; wherein said tubular structure is characterized by a surface area within the range of about 11.4 to about 53.8 square millimeters per millimeter of length of said tubular structure, and the amount of said paclitaxel is within the range of about 0.002 to about 0.175 micrograms per square millimeter of said surface area.
21. The medical implant of claim 20 , wherein the amount of paclitaxel is within the range of about 0.002 to about 0.02 micrograms per square millimeter of said surface area.